Data provided by McGregor BFA
All data is delayed
Loading...
See More
Where am I? Home

Aspen finalises GSK deal for £164m

Dec 03 2012 08:22 Reuters

Shutterstock

Related Articles

Aspen boosts profit, Asian unit robust

Aspen buys GSK Aussie drugs for R2.2bn

Aspen unit to buy drug portfolio from GSK

Aspen prepared to help bridge ARV shortages

Aspen buys GSK brands

Aspen: Earning to between rise 18%-24%

 

Johannesburg - Aspen Pharmacare Holdings [JSE:APN] said on Monday it has finalised the acquisition of medicines from GlaxoSmithKline for £163.8m.

The deal, announced in August, was initially pegged at £172m.

 
NEXT ON FIN24X

J&J says it won't enforce AIDS drug patent

2012-11-30 07:58

 
 
Comment on this story
0 comments
Add your comment
avatar
Logout
Comment 0 characters remaining
 

Most Popular

Company Snapshot

For detailed Unit Trust information, click here.

We're Talking About...

The Debt Issue

The Debt Issue brings you the latest debt news, tips on how to deal with and avoid debt, a panel of debt experts and real life debt stories from across South Africa.
 
Related links:

Blogs

Read more blogs

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Sake24 For business news in Afrikaans, visit

Services

AnswerIt Get your financial questions answered.

RSS Feeds News delivered really simply.

Calculators Easy-to-use personal finance tools.

Newsletters You choose what you want.

Blogs Your opinion on you, me and everyone.

Data Products Get us in your home, on your television.

Contact us Lost? Confused? Problems? Let us help you.

RSS feeds  |  Terms and Conditions  |  Advertise on Fin24  |  Contact us
Loading...